No Detail Found!

Brevilin A Binds with Neh1 Domain of NRF2 and Inhibits its Translocation into Nucleus in Cancer Cells

Author(s)
Sameena Gul Cancer Research Lab, Institute of Zoology, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan
Muhammad Akhtar Ali School of Biological Sciences, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan
Muhammad Khan Cancer Research Lab, Institute of Zoology, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan
Abstract
Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcriptional factor which is constitutively activated in various cancers where it confer survival advantages by transcribing cytoprotective genes involved in cancer initiation, progression, metastasis and development of drug resistance. Here in this study, we have identified and validated Brevilin A (BLN-A), a potent anticancer bioactive compound as potential NRF2 inhibitor using in silico and in-vitro studies. We predicted NRF2 structure by AlphaFold, validated it by diferent approaches, performed its molecular docking, and MD simulation by computational methods. Our findings showed that BLN-A binds with Neh1 (DNA-binding) domain of NRF2 through multiple interactions including hydrogen bonds and hydrophilic interactions. Molecular dynamic simulations accomplished by RMSD (root mean square deviation), RMSF (root mean sequer lfuctuation) and RG (radius of gyration) exhibited the stability, flexibility and compactness of BLN-A and NRF2 complex over 100 ns. Our western blot analysis showed that BLN-A inhibited the translocation of NRF2 into nucleus in a dose-dependent manner in A549 lung cancer and Hey-T30 taxol-resistant ovarian cancer cells. Moreover, BLN-A exhibits drug likeness properties. Therefore, BLN-A could be developed into a potent NRF2 inhibitor for multiple therapeutic efects.
Publication Details
Page(s) 1925-1932
Published Journal: Pakistan Journal of Zoology, Volume: 57, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
molecular docking, western blot, MD simulation, NRF2 inhibitor, Brevilin A
References
Abdullahi S.H.,Uzairu A.,Shallangwa G.A.,Uba S.,Umar A.B. .2022 .Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen2-ones analogues as anti-cancer agents. Bull. Nat. Res, 46 : 177.
Adelusi T.I.,Oyedele A.Q.K.,Boyenle I.D.,Ogunlana A.T.,Adeyemi R.O.,Ukachi C.D.,Idris M.O.,Olaoba O.T.,Adedotun I.O.,Kolawole O.E.,Xiaoxing Y. .2022 .Molecular modeling in drug discovery. Inf. Med, 29 : 100880.
Bamidele J.O.,Ambrose G.O.,Alakanse O.S. .2020 .Selection of oxypeucedanin as a potential antagonist from molecular docking analysis of HSP90. -0136, 7 : 867-875.
Ding Y.,Zhen Z.,Nisar M. A.,Ali F.,Din R. U.,Khan M.,Mughal T. A.,Alam G.,Liu L.,Saleem M.Z. .2022 .Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1/STAT3/ FUT4 Axis and P-glycoprotein transporters in lung cancer cells. Front. Pharmacol., 13 : 795613.
Dong L.,He J.,Luo L.,Wang K. .2023 .Targeting the interplay of autophagy and ROS for cancer therapy: An updated overview on phytochemicals. Pharmaceuticals, 16 : 92.
Gul S.,Muhammad S.,Irfan M.,Belali T.M.,Chaudhry A.R.,Khan M. .2024 .Discovery of potential natural STAT3 inhibitors: An in silico molecular docking and molecular dynamics study. J. Comput. Biophys. Chem, 23 : 189-205.
Harini M.,Kavitha K.,Prabakaran V.,Krithika A.,Dinesh S.,Rajalakshmi A.,Suresh G.,Puvanakrishnan R.,Ramesh B. .2024 .Identification of apigenin-4'-glucoside as bacterial DNA gyrase inhibitor by QSAR modeling, molecular docking, DFT, molecular dynamics, and in vitro confirmation studies. J. mol. Model, 30 : 1-14.
Ilyas M.,Muhammad S.,Iqbal J.,Amin S.,Al-Sehemi A. G.,Algarni H.,Alarfaji S.S.,Alshahrani S.S.,Ayub K. .2022 .Insighting isatin derivatives as potential antiviral agents against NSP3 of COVID-19. , 76 : 6271-6285.
Jumper J.,Evans R.,Pritzel A.,Green T.,Figurnov M.,Ronneberger K.,Bates R.,Žídek A.,Potapenko A.,Bridgland A.,Hassabis D. .2021 .Highly accurate protein structure prediction with AlphaFold. Nature, 596 : 583-589.
Khan M.,Maryam A.,Saleem M.Z.,Shakir H.A.,Qazi J.I.,Li Y. .2020 .Brevilin A induces ROS-dependent apoptosis and suppresses STAT3 activation by direct binding in human lung cancer cells. J. Cancer, 11 : 3725-3735.
Lagorce D.,Douguet D.,Miteva M.A.,Villoutreix B.O. .2017 .Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors. Sci. Rep, 7 : 46277.
Lee G.R.,Won J.,Heo L.,Seok C. .2019 .Simultaneous refinement of inaccurate local regions and overall protein structure. Nucl. Acids Res, 47 : 451-455.
Lee S.,Hu L. .2020 .Nrf2 activation through the inhibition of Keap1-Nrf2 protein-protein interaction. Med. Chem. Res., 29 : 846-867.
Li Z.,Khan M.,Liu C.,Cui X.,Li Y. .2019 .Piceatannol inhibits akt activation, induces G2/M phase arrest and mitochondrial apoptosis and augments cisplatin eficacy in u2os osteosarcoma cells. Pakistan J. Zool, 51 : 2337-2344.
Liu L.,Chen X.,Yuan Y.,Hu Q.,Tang J.,Xie C. .2022 .Brevilin A ameliorates acute lung injury and inflammation through inhibition of NF-κB signaling via targeting IKKα/β. , 13 : 911157.
Liu M.,Lv J.,Chen L.,Li W.,W. W. .2022 .In silico discovery of anticancer peptides from Sanghuang. Int. J. mol. Sci, 23 : 13682.
Liu T.,Lv Y.F.,Zhao J.L.,You Q.D.,Jiang Z.Y. .2021 .Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implications. Free Radic. Biol. Med, 03 : 129-141.
Madden S.K.,Itzhaki L.S. .2020 .Structural and mechanistic insights into the Keap1-Nrf2 system as a route to drug discovery. Biochim. Biophys. Acta Proteins Proteom, : .
Martínez L. .2015 .Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS One, 10 : .
Maryam A.,Mehmood T.,Li H.,Khan Y.,M. Y. .2017 .Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress. Sci. Rep, 7 : 6242.
Meng M.,Tan J.,Chen H.,Shi Z.,Kwan Z.,Su T. .2023 .Brevilin A exerts anti-colorectal cancer efects and potently inhibits STAT3 signaling in vitro. Heliyon, 9 : .
Olasupo S.B.,Uzairu A.,Shallangwa G.,Uba S. .2020 .QSAR modeling, molecular docking and ADMET/pharmacokinetic studies: A chemometrics approach to search for novel inhibitors of norepinephrine transporter as potent antipsychotic drugs. J. Iran. Chem. Soc., 17 : 1953-1966.
Ooi B.K.,Chan K.G.,Goh B.H.,Yap W.H. .2018 .The role of natural products in targeting cardiovascular diseases via Nrf2 pathway: novel molecular mechanisms and therapeutic approaches. , 9 : 1308.
Padhi A.K.,Rath S.L.,Tripathi T. .2021 .Accelerating COVID-19 research using molecular dynamics simulation. J. Phys. Chem. B, 125 : 9078-9091.
Panieri E.,Saso L. .2019 .Potential applications of NRF2 inhibitors in cancer therapy. Oxid. Med, : .
Panieri E.,Buha A.,Telkoparan-Akillilar P.,Cevik D.,Kouretas D.,Veskoukis A.,Skaperda Z.,Tsatsakis A.,Wallace D.,Suzen S.,Saso L. .2020 .Potential applications of NRF2 modulators in cancer therapy. Antioxidants, 9 : 193.
Rajguru T.,Bora D.,Modi M.K. .2021 .Identification of promising inhibitors for Plasmodium haemoglobinase Falcipain-2, using virtual screening, molecular docking, and MD simulation. J. mol. Struct, 1248 : 131427.
Rizwana S.,Maqbool M.F.,Maryam A.,Bashir E.,Khan M.,Khan B.N.,Shakir H.A.,Irfan M. .2023 .Identification and characterization of sesquiterpene lactones as potential falcipain-2 inhibitors: Sesquiterpene lactones as potential falcipain-2 inhibitors. , : 901-21.
Saba A.,Sarwar F.,Muhammad S.,Ilyas M.,Iqbal J.,Al-Sehemi A.G.,Ayub K.,Gilani M.A.,Adnan M. .2022 .Insighting the inhibitory potential of novel modafinil drug derivatives against estrogen alpha (ERα) of breast cancer through a triple hybrid computational methodology. J. mol. Liq, 366 : 120234.
Saikat A.S.M.,Kabir M.L.,Khalipha A.B.R. .2020 .An in silico approach for structural and functional annotation of uncharacterized protein Rv0986 present in Mycobacterium tuberculosis. Eur. J. med. Hlth. Sci., 2 : 61-67.
Sajadimajd S.,Khazaei M. .2018 .Oxidative stress and cancer: The role of Nrf2. Curr. Cancer Drug Targets, 18 : 538-557.
Saleem M.Z.,Nisar M.A.,Alshwmi M.,Din S.R.U.,Gamallat Y.,Khan M. .2020 .Brevilin A inhibits STAT3 signaling and induces ROSDependent apoptosis, mitochondrial stress and endoplasmic reticulum stress in MCF-7 breast cancer cells. Oncol. Targets Ther, 13 : 435-450.
Su T.,Wang Y.P.,Wang X.N.,Li C.Y.,Zhu P.L.,Huang Y.M.,Yang Z.Y.,Chen S.B.,Yu Z.L. .2019 .The JAK2/STAT3 pathway is involved in the anti-melanoma efects of brevilin A. Life Sci. , 241 : 117169.
Telkoparan-Akillilar P.,Panieri E.,Cevik D.,Suzen S.,Saso L. .2021 .Therapeutic targeting of the NRF2 signaling pathway in cancer. Molecules, 26 : 1417.
Ulasov A.V.,Rosenkranz A.A.,Georgiev G.P.,Sobolev A.S. .2021 .Towards specific regulation. Life Sci, 291 : .
Wang J.,Li M.,Cui X.,Lv D.,Jin L.,Khan M. .2018 .Brevilin A promotes oxidative stress and induces mitochondrial apoptosis in U87 glioblastoma cells. Onco. Targets Ther, 11 : 7031-7040.
Xue D.,Zhou X. .2020 .EmergingroleofNRF2 in ROS-mediated tumor chemoresistance. Biomed, 13 : 110676.
You P.,Wu H.,Deng M.,Peng J.,Li F.,Yang Y. .2017 .Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation. , 12 : 619-625.
Zhang ,Xu H.X.,Zhu J.Q.,Dou Y.X.,Xian Y.F.,Lin Z.X. .2023 .Natural Nrf2 inhibitors: A review of their potential for cancer treatment. Int. J. biol. Sci., 19 : 3029.
Zhang X.,Xia Y.,Yang L.,He J.,Li Y.,Xia C. .2019 .Brevilin a, a sesquiterpene lactone, inhibits the replication of influenza a virus in vitro and in vivo. Viruses, 11 : 835.
0

Citations

0

Downloads

72

Views